Clinical Trial Update: Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma [NA]

View source ↗

Summary

Completed clinical trial evaluating fluciclovine-PET/CT for detecting bone metastases in prostate adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• fluciclovine-PET/CT (fluciclovine)

Snippet

Sponsor: University of Arizona | Conditions: Prostate Adenocarcinoma | NA | Status: COMPLETED | Results posted: 2022-08-09